CLINICAL_TRIALS
trial_result
· 2023-03-03
Clinical Trial Update: Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection [Phase 3]
Summary
Phase 3 trial comparing ridinilazole to vancomycin for Clostridioides difficile infection has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Summit Therapeutics | Conditions: Clostridioides Difficile Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-03-03